
Shutterstock.com
The number of patients with type 2 diabetes mellitus (T2DM), especially within the black, Asian and ethnic minority community, continues to rise, with the International Diabetes Federation estimating that by 2050, approximately 853 million people will be living with diabetes — an increase of 46% on current incidence rates1. The prevalence among the black, Asian and ethnic minority community became more prominent after the COVID-19 pandemic, which exacerbated existing healthcare inequalities2.
In 2020, when I started working at my GP local practice, located in a diverse community in north west England, approximately 120 out of 215 patients with T2DM did not have an annual urine albumin-creatinine ratio (ACR) in place, despite having up-to-date blood testing. This seems to be a common occurrence with other primary care practices3. ACR screening is important in helping to identify kidney disease early in patients with diabetes4; however, a quality improvement assessment revealed that many patients were unaware of the importance of kidney health as part of their diabetes review.
As of November 2021, there were less than 40 patients without annual ACR in place. The practice has since reduced the number of patients with outstanding ACR results down to single digits.
In implementing regular urine ACR testing for a greater number of people with diabetes, common complaints among patients included having to visit the GP for five to six diabetes-related appointments in a year, seeing different clinicians each time. There were also complaints about waiting up to a year to be referred to a secondary care diabetes clinic.
Part of the education is in helping patients to understand that having a good HbA1c level is as important as a good kidney health or regular eye screening
These complaints served as my motivation to create a one-stop diabetes clinic within the GP practice. The clinic involved a strong working relationship between myself and the healthcare assistant (HCA). We would also seek advice from the GP or secondary care diabetes team in complicated cases.
The diabetes clinic review initially involved patients being booked in with the HCA for routine blood testing, including HbA1c, urea and electrolytes, liver, lipids and full blood count. Patients will also have their feet, blood pressure and weight checked, and an early morning urine sample requested for ACR testing. Patients are then booked into my clinic the following week to review their results.
As a prescribing pharmacist, with a special interest in diabetes, I will sit with each patient for a 15-minute consultation, going through each of the nine ‘key care processes’ for diabetes recommended by the National Institute for Health and Care Excellence (NICE; see Box5). These results can help to identify those at higher risk of cardiovascular disease (CVD), as well as guide the type of medication prescribed to each patient.
Box: Nine key care processes recommended by NICE5
- HbA1c: amend medication if needed;
- Renal blood test (egfr): review result and amend medication. Refer to nephrology if there are major concerns with recent result;
- Blood pressure (BP): review recent BP, ensuring it is within target. Adjust medication if necessary;
- Lipids: Review results using QRISK3 score and amend medication if needed. Advise on diet and lifestyle, as well as the provision of NHS resources on healthy food substitutes and exercise;
- BMI: review BMI and advise on weight management, if required, or refer. BMI may also guide the prescribing of diabetes medication;
- Urine ACR: review results and prescribe medication, if needed;
- Smoking status: check there is an annual recording, advise or offer smoking cessation referral, if needed. Smoking status is also relevant in assessing cardiovascular disease risk;
- Foot check: review results of the healthcare assistant examination and prescribe antifungals or emollients for dry skin, if necessary;
- Retinopathy eye screening: if there is no annual result on record, provide the patient with the link to rebook missed appointment. If retinopathy is present, review HbA1c/BP control. Presence and degree of retinopathy can also guide prescribing.
Once the comprehensive review is done, the patient is booked in for a follow-up consultation, either to repeat their blood test after 12 weeks, depending on the medication they were taking, or they may be referred to a secondary care diabetes clinic if they are already on and compliant with the maximum dose of diabetes medication, with no changes to their results. If all nine of NICE’s key care areas are complete, I will code the patient in our IT system as ‘satisfactory’.
Setting up this one-stop diabetes clinic has benefited patients, as well as the GP practice. Offering a pharmacist-led consultation enables patients to speak to a medication expert about all diabetes-related issues in one appointment, reducing the number of appointments they need to attend, while facilitating patient education on NICE’s nine key care processes.
Part of the education is in helping patients to understand that having a good HbA1c level is as important as a good kidney health or regular eye screening. This has helped empower our patients to take ownership of their diabetes health. Patients having all their reviews completed within a maximum of two or three clinic appointments has also been beneficial to our GP practice, freeing up more time for the GPs to deal with complicated acute cases, while enabling the nurses to focus on other long-term conditions. While enhancing my own skills as a specialist pharmacist, the clinic has helped reduce overall hospital admissions from diabetes-related complications. By January 2025, the GP practice had acquired mostly all diabetes-related points under the Quality and Outcomes Framework (QOF).
- 1.Diabetes Facts and Figures. International Diabetes Federation. 2025. Accessed June 2025. https://idf.org/about-diabetes/diabetes-facts-figures/
- 2.Khunti K. Diabetes, ethnic minority groups and <scp>COVID</scp>‐19: an inevitable storm. Practical Diabetes. 2022;39(5):13-18. doi:10.1002/pdi.2414
- 3.Baig A, Zafar A. Urine ACR uptake in patients with a diagnosis of type 1 and 2 diabetes mellitus in a primary care setting: A cross sectional study. Primary Care Diabetes. 2023;17(6):639-642. doi:10.1016/j.pcd.2023.10.005
- 4.Urine albumin to creatinine ratio (ACR). NHS. May 2022. Accessed June 2025. https://www.nhs.uk/conditions/acr-test/
- 5.Type 2 diabetes in adults — Quality standard Reference number: QS209. National Institiute for Health and Care Excellence. March 2023. Accessed June 2025. https://www.nice.org.uk/guidance/qs209/chapter/Quality-statement-6-9-key-care-processes
You may also be interested in

Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows

ICBs may commission community pharmacies to offer diabetic eye screenings from 2026, says NHS England
